<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: Whether transplanted cardiac stem cells (<z:chebi fb="11" ids="17437,53115">CSCs</z:chebi>) and mesenchymal stem cells (MSCs) improved <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> threshold (VFT) similarly is still unclear </plain></SENT>
<SENT sid="1" pm="."><plain>We sought to compare the effects of the <z:chebi fb="11" ids="17437,53115">CSC</z:chebi> and MSC transplantation on the electrophysiological characteristics and VFT in rats with <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> (MI) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: MI was induced in 30 male Sprague-Dawley rats </plain></SENT>
<SENT sid="3" pm="."><plain>Two weeks later, animals were randomized to receive 5 × 10(6) <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi> labeled with PKH26 in PBS or 5 × 10(6) MSCs labeled with PKH26 in phosphate buffer solution(PBS) or PBS alone injection into the infarcted anterior ventricular free wall </plain></SENT>
<SENT sid="4" pm="."><plain>Six weeks after the injection, electrophysiological characteristics and VFT were measured </plain></SENT>
<SENT sid="5" pm="."><plain>Labeled <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi> and MSCs were observed in 5 μm cryostat sections from each heart </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Malignant <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> were significantly (P = 0.0055) less inducible in the <z:chebi fb="11" ids="17437,53115">CSC</z:chebi> group than the MSC group </plain></SENT>
<SENT sid="7" pm="."><plain>The VFTs were improved in the <z:chebi fb="11" ids="17437,53115">CSC</z:chebi> group compared with the MSC group </plain></SENT>
<SENT sid="8" pm="."><plain>Labeled <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi> and MSCs were identified in the <z:mpath ids='MPATH_124'>infarct</z:mpath> zone and <z:mpath ids='MPATH_124'>infarct</z:mpath> marginal zone </plain></SENT>
<SENT sid="9" pm="."><plain>Labeled <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi> expressed Connexin-43, <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor, α-smooth muscle actin and α-sarcomeric actin,while the Labeled MSCs expressed <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor, α-smooth muscle actin and α-sarcomeric actin in vivo </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: After 6 weeks of cell transplantation, <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi> are superior to MSCs in modulating the electrophysiological abnormality and improving the VFT in rats with MI </plain></SENT>
<SENT sid="11" pm="."><plain><z:chebi fb="11" ids="17437,53115">CSCs</z:chebi> and MSCs express markers that suggest muscle, endothelium and vascular smooth <z:mp ids='MP_0005369'>muscle phenotypes</z:mp> in vivo, but MSCs rarely express Connexin-43 </plain></SENT>
</text></document>